Skip to content

Internet Delivered Cognitive Behavior Therapy Based on Intolerance of Uncertainty

Effects and Mechanisms of Change of Two Different Treatments Targeting Worry in Generalised Anxiety Disorder: Study 1 - IU Pilot

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05820568
Acronym
ORIGAMI
Enrollment
22
Registered
2023-04-19
Start date
2022-11-02
Completion date
2023-05-22
Last updated
2023-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized Anxiety Disorder

Keywords

internet delivered treatment, digital mental health services, psychiatry, cognitive behavior therapy, intolerance of uncertainty

Brief summary

The goal of this clinical is to pilot test an internet delivered cognitive behavior therapy (ICBT) based on intolerance of uncertainty (one of several existing specific cognitive models for how worry works) in treating generalised anxiety disorder (GAD). The main aims is to: * Test the preliminary effect of the intervention in lowering symptoms of GAD as measured by the self report scale GAD-7 * Test procedures for recruitment, assessment, treatment and follow up * Test the acceptability of the intervention as measured by the Client Satisfaction questionnaire-8, dropout and adverse events Participants will apply for treatment in an online system, be assessed via video by a licensed clinical psychologist and then receive a 10 week long ICBT intervention based on the intolerance of uncertainty model. This is a pilot study for an upcoming randomized controlled trial.

Interventions

BEHAVIORALICBT-IU

Internet delivered Cognitive Behavior Therapy for Generalized Anxiety Disorder based on the Intolerance of uncertainty model of worry

Sponsors

Region Stockholm
CollaboratorOTHER_GOV
Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Pilot

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years old or more. * Diagnosis of GAD based on clinical assessment. * At least 10 points on GAD-7 at screening. * Proficient in written Swedish. * Access to internet enabled device and Swedish BankID for authentication * Able to make sufficient time for the 10 week long treatment * Consents to study

Exclusion criteria

* In need of treatment for other psychiatric diagnosis as priority (eg depression, psychosis) or high risk of suicide based on clinical assessment * Ongoing risk use of alcohol or drugs * Ongoing serious somatic of social disease/problem that is deemed to be to much of a hindrance for the completion of the treatment

Design outcomes

Primary

MeasureTime frameDescription
Generalized Anxiety Disorder 7-item (GAD7)10 weeks after treatment startSymptoms of generalized anxiety disorder measured by the self report measure GAD7. Scores range from 0-21 with higher scores indicating more generalized anxiety

Secondary

MeasureTime frameDescription
Satisfaction with treatment10 weeks after treatment startClient Satisfaction Questionnaire 8 item version (CSQ8). Scores range from 8 to 32; scores of 8-13 indicate poor satisfaction, 14-19 fair satisfaction, 20-25 good satisfaction, and 26-32 excellent satisfaction.
Symptoms of depression including suicidal ideation10 weeks after treatment startMeasured with the Montgomery Åsberg Depression Rating Scale- Self report (MADRS-S). Scores range from 0-54 with higher scores indicating more depression
Intolerance of uncertainty10 weeks after treatment startMeasured with the Intolerance of Uncertainty Scale short version (IUS-12). Scores range from 12-60 with higher scores indicating more intolerance of uncertainty.
Excessive worry10 weeks after treatment startMeasured with the Penn State Worry Questionnaore (PSWQ). Scores range from 16-80 points with more points indicating more worry
Symptoms of depression10 weeks after treatment startMeasured with the Patient Health Questionnaire-9 item self report measure (PHQ9).The scale range is 0-27 with higher scores indication more depression.
WHO Disability Assessment Schedule (WHODAS 2.0) self report (12 items)10 weeks after treatment startA health and disability metric developed by WHO. Scores range from 0-100% and represent the level of disability with 100% being complete disability to function in everyday life.
Treatment credibility2 weeks into treatmentA version of the credibility expectancy questionnaire used at the Internet Psychiatry Clinic in Sweden. Scores range from 5 to 50 with higher scores indicating more credibility.

Other

MeasureTime frameDescription
Rate of treatment dropout10 weeks after treatment startPatient terminates treatment ahead of schedule
Adherence10 weeks after treatment startNumber of modules completed

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026